Table 2.
Ninety Day Stroke Outcomes in Midlife Stroke Patients Aged 45–64 and Comparisons with Stroke Patients Age ≥ 65.
| Age 45–64 Median (IQR) |
Age ≥ 65 Median (IQR) |
Unadjusted Diff (95% CI) |
Adjusted* Diff (95% CI)† |
Adjusted** Diff (95% CI)† |
|
|---|---|---|---|---|---|
| Functional outcome: ADL/IADL Score (Range 1–4, higher worse) |
1.98 (1.27, 2.73) | 2.77 (1.64, 3.68) | −0.60 (−0.77, −0.42) | −0.60 (−0.77, −0.43) | −0.53 (−0.71, −0.36) |
| Neurologic outcome: NIHSS (Range 0–42, higher worse) |
2 (0, 4) | 3 (1, 7) | −0.89 (−1.40, −0.38) | −1.17 (−1.73, −0.62) | −0.84 (−1.34, −0.35) |
| Cognitive outcome: 3MSE (Range 0–100, higher better) |
92 (85, 96) | 85 (70, 94) | 6.90 (4.71, 9.08) | 7.46 (5.31, 9.60) | 5.71 (3.83, 7.59) |
| Quality of life: SS-QOL (Range 1–5, higher better) |
3.33 (2.58, 4.29) | 3.33 (2.33, 4.25) | 0.10 (−0.14, 0.35) | 0.13 (−0.12, 0.38) | 0.06 (−0.19, 0.32) |
Adjusted for sex and ethnicity
Adjusted for sex, ethnicity and educational attainment
Adjusted for sex, ethnicity, education
Estimates from linear regression with robust standard errors adjusted for sex and ethnicity
ADL/IADL activities of daily living/instrumental activities of daily living, NIHSS National Institutes of Health Stroke Scale, 3MSE Modified Minimental State Examination, SS-QOL short form Stroke-Specific Quality of Life
NOTE: ADL/IADL sample size for age 45–65 (N=260) and age ≥65 (N=339); NIHSS sample size for age 45–65 (N=262) and age ≥65 (N=337); 3MSE sample size for age 45–65 (N=247) and age ≥65 (N=250); SS-QOL collected from May 1, 2010; sample size for ages 45–64 (N=148) and age ≥65 (N=181).